Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

One Company That's Set to Win From Precision Medicine
One Company That's Set to Win From Precision Medicine
In the last few decades, incredible strides have been made in genome typing and precision medicine technology. What used to cost hundreds of thousands of dollars is now available for $100, opening up
One Company That's Set to Win From Precision Medicine
One Company That's Set to Win From Precision Medicine
In the last few decades, incredible strides have been made in genome typing and precision medicine technology. What used to cost hundreds of thousands of dollars is now available for $100, opening up
One Company That's Set to Win From Precision Medicine
One Company That's Set to Win From Precision Medicine
In the last few decades, incredible strides have been made in genome typing and precision medicine technology. What used to cost hundreds of thousands of dollars is now available for $100, opening up
2 Very Different Market Reactions to Priceline and TripAdvisor's Strong Quarters
2 Very Different Market Reactions to Priceline and TripAdvisor's Strong Quarters
In this Motley Fool Money podcast segment, host Chris Hill, Million Dollar Portfolio's Jason Moser, and Total Income's Ron Gross discuss the online travel agencies' earnings results, which were solid
Blue Apron's Failed Execution Just Opened the Door for the Competition
Blue Apron's Failed Execution Just Opened the Door for the Competition
Blue Apron (NYSE: APRN) reported disappointing earnings results last week. While its revenue came in above expectations, it reported a bigger loss per share than most were hoping for.But that's not
Blue Apron's Failed Execution Just Opened the Door for the Competition
Blue Apron's Failed Execution Just Opened the Door for the Competition
Blue Apron (NYSE: APRN) reported disappointing earnings results last week. While its revenue came in above expectations, it reported a bigger loss per share than most were hoping for.But that's not
Blue Apron's Failed Execution Just Opened the Door for the Competition
Blue Apron's Failed Execution Just Opened the Door for the Competition
Blue Apron (NYSE: APRN) reported disappointing earnings results last week. While its revenue came in above expectations, it reported a bigger loss per share than most were hoping for.But that's not
Why Coach, Windstream Holdings, and YY Slumped Today
Why Coach, Windstream Holdings, and YY Slumped Today
Tuesday was relatively calm on Wall Street, with major benchmarks finishing with mixed results but staying close to where they began the day. Absent big market-shifting news, a lot of individual
Why Disney Had to Launch Streaming Services
Why Disney Had to Launch Streaming Services
In this Motley Fool Money podcast segment, host Chris Hill, Million Dollar Portfolio's Jason Moser and Matt Argersinger, and Total Income's Ron Gross dig into the revelations from Bob Iger about his
Why Disney Had to Launch Streaming Services
Why Disney Had to Launch Streaming Services
In this Motley Fool Money podcast segment, host Chris Hill, Million Dollar Portfolio's Jason Moser and Matt Argersinger, and Total Income's Ron Gross dig into the revelations from Bob Iger about his
Why Disney Had to Launch Streaming Services
Why Disney Had to Launch Streaming Services
In this Motley Fool Money podcast segment, host Chris Hill, Million Dollar Portfolio's Jason Moser and Matt Argersinger, and Total Income's Ron Gross dig into the revelations from Bob Iger about his
Why Shares of Photronics Tumbled Today
Why Shares of Photronics Tumbled Today
Shares of photomask manufacturer Photronics (NASDAQ: PLAB) slumped on Tuesday following the company's third-quarter results and news that the CFO was retiring. Photronics missed analyst estimates for
Why Wynn Resorts, Extreme Networks, and Calumet Specialty Products Partners Jumped Today
Why Wynn Resorts, Extreme Networks, and Calumet Specialty Products Partners Jumped Today
Major benchmarks didn't make any big moves on Tuesday, as market participants largely turned their attention toward the latest maneuverings among Wall Street's institutional investors. Quarterly
Why Wynn Resorts, Extreme Networks, and Calumet Specialty Products Partners Jumped Today
Why Wynn Resorts, Extreme Networks, and Calumet Specialty Products Partners Jumped Today
Major benchmarks didn't make any big moves on Tuesday, as market participants largely turned their attention toward the latest maneuverings among Wall Street's institutional investors. Quarterly
Why Westport Fuel Systems Inc.'s Shares Popped 15% Today
Why Westport Fuel Systems Inc.'s Shares Popped 15% Today
Shares of natural gas technology company Westport Fuel Systems Inc. (NASDAQ: WPRT) jumped as much as 15.2% in trading Tuesday, after the company posted second-quarter earnings. A year after it merged
How Shopify Inc. Makes Most of Its Money
How Shopify Inc. Makes Most of Its Money
Investors in Shopify (NYSE: SHOP) have seen their stock double in 2017 alone and triple in two short years on the public market. That's an undeniably awesome return on your investment, but how does
Why Gilead Sciences Might Not Make an Oncology Acquisition
Why Gilead Sciences Might Not Make an Oncology Acquisition
Is Gilead Sciences (NASDAQ: GILD) backing away from its plans to acquire a smaller biotech focusing on oncology? That could be the case. Gilead CEO John Milligan reportedly told Leerink analyst
Why Gilead Sciences Might Not Make an Oncology Acquisition
Why Gilead Sciences Might Not Make an Oncology Acquisition
Is Gilead Sciences (NASDAQ: GILD) backing away from its plans to acquire a smaller biotech focusing on oncology? That could be the case. Gilead CEO John Milligan reportedly told Leerink analyst
Why Gilead Sciences Might Not Make an Oncology Acquisition
Why Gilead Sciences Might Not Make an Oncology Acquisition
Is Gilead Sciences (NASDAQ: GILD) backing away from its plans to acquire a smaller biotech focusing on oncology? That could be the case. Gilead CEO John Milligan reportedly told Leerink analyst
So This Is Why Facebook Wanted WhatsApp So Badly
So This Is Why Facebook Wanted WhatsApp So Badly
I've long been a skeptic of Facebook's (NASDAQ: FB) massive WhatsApp acquisition, mostly because I still think the social network overpaid, which in turn creates significant impairment risk for all
So This Is Why Facebook Wanted WhatsApp So Badly
So This Is Why Facebook Wanted WhatsApp So Badly
I've long been a skeptic of Facebook's (NASDAQ: FB) massive WhatsApp acquisition, mostly because I still think the social network overpaid, which in turn creates significant impairment risk for all
So This Is Why Facebook Wanted WhatsApp So Badly
So This Is Why Facebook Wanted WhatsApp So Badly
I've long been a skeptic of Facebook's (NASDAQ: FB) massive WhatsApp acquisition, mostly because I still think the social network overpaid, which in turn creates significant impairment risk for all
Disney World's Top Rival Has a New Trick Up Its Sleeve
Disney World's Top Rival Has a New Trick Up Its Sleeve
Disney's (NYSE: DIS) biggest rival in Central Florida knows that it needs more than just a single new hit to take on the onslaught of new attractions coming to Disney World in the coming years
Disney World's Top Rival Has a New Trick Up Its Sleeve
Disney World's Top Rival Has a New Trick Up Its Sleeve
Disney's (NYSE: DIS) biggest rival in Central Florida knows that it needs more than just a single new hit to take on the onslaught of new attractions coming to Disney World in the coming years
Customer Traffic Gains Power a 14% Spike in Home Depot Inc. Earnings
Customer Traffic Gains Power a 14% Spike in Home Depot Inc. Earnings
Home Depot (NYSE: HD) posted quarterly results this week that were highlighted by accelerating sales gains and a double-digit boost in profits. The retailer also raised its top-line and bottom-line